News

In a conversation with Outsourcing Pharma at CPHI Barcelona, Paul Quigley, principal research fellow of drug substance at Quotient Sciences, explained how continuous flow manufacturing is taking off in the production of active pharmaceutical ingredients (APIs).

Nick McEntee, Executive Director, Head of UK GMP Operations discusses strategies for flexible, on-demand manufacture of clinical trial materials with Contract Pharma.

Quotient Sciences' Nand Singh featured in BJCP's article on 'Evaluation of the drug disposition of RO7049389 with in vitro data and human mass balance supported by physiologically based pharmacokinetic modeling'.

Eleanor Row discusses the challenges and considerations that drug developers should be aware of when quickly advancing their molecules from discovery to the investigational new drug (IND) stage and onward into the clinic, while emphasizing the benefits of an integrated approach to accelerate the process.

During DCAT Week 2023, Sarah Stevens, senior vice-president and head of Drug Product Development & Manufacturing at Quotient Sciences, discussed various facets of the modern pharmaceutical outsourcing industry with Grant Playter, associate editor of Pharm Tech.

European Pharma Manufacturing and Drug Discovery World ask Quotient Sciences' Dr. Asma Patel, VP of Integrated Services for Early Development, about what barriers remain in rare disease drug development.